Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1284 of 5804
-
Digital care plans after kidney injury could save lives
Disease control Recruiting nowNearly one in ten people who are hospitalized in Canada develop a complication with sudden loss of kidney function, called acute kidney injury (AKI). AKI may lead to other severe health problems after discharge home, such as kidney failure requiring dialysis treatment, heart fail…
Phase: NA • Sponsor: University of Alberta • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Can magnetic pulses boost speech therapy for stroke survivors?
Symptom relief Recruiting nowThe goal of this clinical trial is to determine if Transcranial Magnetic Stimulation (TMS) combined with Speech-Language Therapy (SLT) is an effective treatment for mild aphasia in persons with chronic stroke. The main questions this study aims to answer are: 1. Can TMS combine…
Phase: PHASE2 • Sponsor: University of Pennsylvania • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
New gel stent could help glaucoma patients see clearly
Disease control Recruiting nowGlaucoma is the second most common cause of blindness in the world, second only to cataracts. This study will assess how safe and effective a glaucoma gel stent is when implanted using the ab interno (inside the eye) and ab externo (outside the eye) approach. Adverse events and i…
Phase: PHASE3 • Sponsor: AbbVie • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New stent aims to help cancer patients eat again without surgery
Symptom relief TerminatedTo investigate the safety and technical success of EUS-guided gastroenterostomy (EUS-GE) using the AXIOSTM lumen-apposing Metal Stent for the management of symptoms associated with gastric outlet obstruction from malignant unresectable neoplasm.
Phase: NA • Sponsor: Boston Scientific Corporation • Aim: Symptom relief
Last updated Jul 10, 2026 00:00 UTC
-
Could a simple multivitamin boost birth weights in bangladesh?
Disease control OngoingBackground Maternal undernutrition and micronutrient deficiencies remain highly prevalent in Bangladesh and contribute to maternal anaemia, low birth weight, preterm birth, and adverse neonatal outcomes. Although iron-folic acid supplementation (IFAS) is routinely provided throug…
Phase: PHASE1, PHASE2 • Sponsor: National Institute of Neurosciences and Hospital, Dhaka • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Breathing device may shield heart during breast cancer radiation
Symptom relief Recruiting nowThis study is a prospective, non-randomized clinical study aimed at investigating the potential benefits of continuous positive airway pressure (CPAP) support during radiotherapy for breast cancer. CPAP is a device commonly used to support breathing, for example in patients with …
Phase: PHASE2, PHASE3 • Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Gene test could help teens get the right antidepressant dose faster
Symptom relief Recruiting nowThis is a parallel arm randomized (1:1) controlled trial. Adolescents aged 12-17 years (n=228) who are starting or changing a selective serotonin reuptake inhibitor (SSRI) for depression and/or anxiety will be randomly allocated to receive 12-weeks of pharmacogenetic-guided antid…
Phase: NA • Sponsor: University of Calgary • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Eye-Tracking test could spot autism in toddlers
Diagnosis Recruiting nowThe study will use a non-invasive remote eye-tracking system (Eyelink Portable Duo) to acquire a short series of eye-tracking measures to determine whether these can predict autism diagnoses in both children exposed to HIV and uninfected (CHEU) and children not exposed to HIV and…
Phase: NA • Sponsor: Indiana University • Aim: Diagnosis
Last updated Jun 27, 2026 12:38 UTC
-
Can a brief chat ease suicidal thoughts in teens?
Symptom relief CompletedThis project is designed to test a brief therapy to reduce suicidal ideation among a diverse sample of youths ages 12 to 17 who experience anxiety or depression. The goal of the study is to conduct a clinical trial testing whether this therapy reduces suicidal ideation and relate…
Phase: NA • Sponsor: Florida International University • Aim: Symptom relief
Last updated Jul 22, 2026 00:00 UTC
-
Lighter chemo, same punch? new combo aims to spare older lung cancer patients harsh side effects
Disease control Recruiting nowEvaluate frequency of adverse events that lead to chemotherapy discontinuation in vulnerable older adults with recurrent/metastatic PD-L1 TPS\<50% NSCLC patients who receive reduced dose chemotherapy in combination with immunotherapy.
Phase: PHASE2 • Sponsor: Virginia Commonwealth University • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New shot may slash cholesterol after heart attacks
Disease control Recruiting nowThis is an open label, patient-level 1:1 randomized clinical trial in a multi-country study aiming to evaluate the real-world impact of inclisiran + Usual Care (UC) vs UC alone on LDL-C lowering, patient-reported outcomes, and healthcare resource utilization in an in-hospital pop…
Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Blood test plus risk score aims to stop heart failure before it starts in diabetes patients
Prevention Recruiting nowA pragmatic, randomized clinical trial to evaluate the effect of a heart failure (HF) risk assessment and prevention strategy incorporating HF clinical risk scores (WATCH-DM) with cardiac biomarker (NT-proBNP) paired with a clinical decision support tool to implement an intensive…
Phase: NA • Sponsor: University of Texas Southwestern Medical Center • Aim: Prevention
Last updated Jun 27, 2026 09:08 UTC
-
New device aims to tame overactive nerves in ALS
Disease control Recruiting nowFollowing completion of the ALS Early Feasibility Study of the MyoRegulator® device for treatment of ALS (NCT06165172), the CALM study will further assess the feasibility of the MyoRegulator® device to treat ALS in an expanded number of individuals with ALS. CALM will gather addi…
Phase: NA • Sponsor: PathMaker Neurosystems Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Pedal away pain: home bikes tested for back relief
Symptom relief Recruiting nowThe main objective of the study is to compare the efficacy on back-specific activity limitations at 4 months after-randomisation of home-based cycling using connected ergometric bicycles associated with usual care to usual care.
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
Tech and community support team up to tackle high blood pressure in latinx communities
Disease control Recruiting nowThis study seeks to evaluate the impact of a remote patient monitoring (RPM)-specific tech-enabled community health worker workforce on the use of RPM for the management of hypertension among Latinx patients. This study is a step-wedge randomized controlled trial that aims to ass…
Phase: NA • Sponsor: NYU Langone Health • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Simple zinc pill may shield kids with sickle cell from deadly infections
Prevention CompletedA randomized double-blinded placebo-controlled trial of zinc to reduce the incidence of severe or invasive infections in Ugandan children with sickle cell anemia (SCA)
Phase: PHASE2, PHASE3 • Sponsor: Indiana University • Aim: Prevention
Last updated Jun 27, 2026 09:00 UTC
-
New gel promises better nerve repair after severe arm injuries
Disease control Recruiting nowNTX-001 is a single use surgical product intended for use in conjunction with standard suture neurorrhaphy of severed nerves in patients between 18 and 80.
Phase: PHASE3 • Sponsor: Neuraptive Therapeutics Inc. • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New hope for Crohn's patients when first drug fails
Disease control Recruiting nowThis is a prospective, single-center, observational study aimed at evaluating the efficacy and safety of guselkumab in patients with moderate to severe Crohn's disease (CD) who have previously failed or were intolerant to ustekinumab therapy. The study plans to enroll approximate…
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
AI stethoscope boosts heart defect detection in kids
Diagnosis CompletedIn recent years, the application of artificial intelligence (AI) in the healthcare domain has witnessed a significant surge, with deep learning emerging as a potent force in the medical field. Deep learning algorithms possess the remarkable ability to automatically extract intric…
Phase: NA • Sponsor: Kun Sun • Aim: Diagnosis
Last updated Jun 27, 2026 12:04 UTC
-
Simple tube change could cut Post-Surgery heart flutter by 30%
Symptom relief Recruiting nowEvacuation of pericardial blood by posterior pericardiotomy or use of a posterior pericardial chest tube lowers postoperative atrial fibrillation (POAF) rates after cardiac surgery by 45-68%. Although it cannot be generalized due to trial undersizing, posterior pericardial chest …
Phase: NA • Sponsor: Region Skane • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC